[EN] P300/CBP HAT INHIBITORS<br/>[FR] INHIBITEURS D'HAT P300/CBP
申请人:CONSTELLATION PHARMACEUTICALS INC
公开号:WO2019161162A1
公开(公告)日:2019-08-22
Provided are compounds of Formula (I): and pharmaceutically acceptable salts and compositions thereof, which are useful for treating a variety of conditions associated with histone acetyltransferase (HAT).